Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to email@email.com
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    email@email.com

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Home > Multinationals > OPKO Health
    Claimed by owner Last Update 19.10.2023 Suggest Edits Claim Profile
    Claimed by owner
    OPKO Health

    OPKO Health

    Pharmaceuticals • United States

    Hidden Profile undefined terms of use
    Public on NASDAQNov, 1995
    Public on TASEAug, 2013
    OPKO Health
    About
    Exits
    Extensions
    Israeli Portfolio
    News
    Gallery
    Sep 12, 2023
    investors.enterabio.com
    Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes | Entera Bio Ltd.
    Mar 8, 2020
    en.globes.co.il
    Opko jumps on Covid-19 diagnostic lab announcement
    #Customers #Investment
    Oct 23, 2019
    en.globes.co.il
    Opko Health seeks $100m in NYSE public offering
    #Investment
    Feb 5, 2019
    en.globes.co.il
    Opko to activate shelf prospectus to raise $200m
    #Investment
    Apr 29, 2018
    www.calcalistech.com
    Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange
    #Public Trading
    Apr 10, 2018
    www.globes.co.il
    Opko Health to delist from TASE
    #Public Trading
    Apr 16, 2014
    www.globes.co.il
    Opko turns Prolor into Israeli R&D, investment arm
    #Acquisition
    Dec 21, 2011
    www.globes.co.il
    OPKO Health buys FineTech Pharmaceutical for $27.5m
    #Acquisition

    About

    OPKO Health Inc is a multinational corporation that researches, develops, and produces a variety of pharmaceutical technologies. The company pursues diagnostics, genetic testing, cancer treatment, fertility, growth hormone deficiency, and other areas of pharmaceutical research.

    OPKO Israel encompasses two main entities: OPKO Biologics and FineTech Pharmaceutical. OPKO Biologics, previously known as Prolor Biotech, is a clinical-stage company that concentrates on creating long-acting versions of therapeutic proteins and peptide drugs. They employ advanced technologies such as CTP, reversible PEGylation, and native stabilizer proteins. On the other hand, FineTech is involved in the development of high-value Active Pharmaceutical Ingredients (APIs) and devises methods to bypass patents, facilitating faster commercial progress for its pharmaceutical clients.

    Founded

    In Israel Since

    Employees Worldwide

    Employees

    Market Cap

    Market Cap Update

    11/2023

    Country

    United States

    News

      (8)
    Sep 12, 2023
    investors.enterabio.com
    Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes | Entera Bio Ltd.
    Mar 8, 2020
    en.globes.co.il
    Opko jumps on Covid-19 diagnostic lab announcement
    #Customers #Investment
    Oct 23, 2019
    en.globes.co.il
    Opko Health seeks $100m in NYSE public offering
    #Investment
    Feb 5, 2019
    en.globes.co.il
    Opko to activate shelf prospectus to raise $200m
    #Investment
    Apr 29, 2018
    www.calcalistech.com
    Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange
    #Public Trading
    Apr 10, 2018
    www.globes.co.il
    Opko Health to delist from TASE
    #Public Trading
    Apr 16, 2014
    www.globes.co.il
    Opko turns Prolor into Israeli R&D, investment arm
    #Acquisition
    Dec 21, 2011
    www.globes.co.il
    OPKO Health buys FineTech Pharmaceutical for $27.5m
    #Acquisition

    The Team

    (1)
    LM
    Laura Moschcovich
    General Manager
    Connect

    Connect with

    What is the reason for connecting? *
    Your company *

    Your organization type *

    Please enter a valid organization type
    Your position *
    Add invitation message
    0/300

    Sending invitation...

    Events

    Locations

    Israel

    Ashlegan 15, Kiryat Gat, Israel

    Offices Abroad

    Miami, FL, USA

    Locations

    Israel

    Ashlegan 15, Kiryat Gat, Israel

    Offices Abroad

    Miami, FL, USA

    Notes

    Content Writer
    undefined
    BI Verification
    undefined
    Phone Number
    undefined
    Israel Register ID
    undefined
    Confidence Score
    undefined
    Missing Fields
    undefined
    Profile Creator
    undefined
    Profile Update
    undefined
    undefined

    Add Article

    0/500